Introduction
============

Osteosarcoma (OS), the most common primary malignancy of bone, can occur at any age, but predominantly develops in adolescents, with \~400 newly diagnosed cases each year in America ([@b1-mmr-19-04-2729]). OS accounts for \~60% of all bone malignancies diagnosed in patients \<20 years old ([@b2-mmr-19-04-2729],[@b3-mmr-19-04-2729]). Several studies reported that disease stage, gender, age, pathology subtypes and primary tumor site of OS result in differences in survival rate, with younger patients exhibiting significant better prognosis and higher survival rate than the elderly ([@b2-mmr-19-04-2729],[@b4-mmr-19-04-2729]). With improved chemotherapy outcomes in the 1980s, the 5-year event-free survival was significantly increased, whereas it has remained stable without any significant improvement in the past 20 years ([@b5-mmr-19-04-2729]--[@b7-mmr-19-04-2729]). Uncovering the tumorigenesis and progression mechanisms is crucial for developing effective molecular targeted therapy. In the past decades, efforts have been made to clarify the molecular basis of OS. Substantial progress has been made using gene expression profiles of OS to reveal the molecular pathogenesis of OS. Age is a prognostic factor of OS insofar as we know; however, few studies have investigated the underlying molecular mechanisms, which may contribute to various outcomes.

Original microarray datasets of 36 OS samples from patients aged \<20 and 6 matched samples aged \>20 (GSE39058) ([@b8-mmr-19-04-2729]), and 58 OS samples from patients aged \<20 and 7 matched samples from patients aged \>20 from human non-coding RNA profiling data (GSE39040) ([@b8-mmr-19-04-2729]), were obtained from the human expression database Gene Expression Omnibus (GEO; <http://www.ncbi.nlm.nih.gov/geo/>). Differentially expressed genes (DEGs) between OS cases aged \<20 and matched cases aged \>20 were screened using R software limma package ([@b9-mmr-19-04-2729]). Gene function analysis, including Gene Ontology (GO) and KOBAS-Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, were performed using the differentially expressed mRNAs on Metascape (<http://metascape.org/gp/>). A regulatory network was constructed by combining the protein-protein interaction (PPI) network with microRNA (miRNA)-mRNA interactions to reveal the potential molecular differences between the different age groups. Kaplan-Meier survival analysis was also performed to clarify our result. In conclusion, the regulatory networks were constructed and the potential important key signaling pathways were analyzed by applying bioinformatics tools to investigate different molecular mechanism of OS among different age groups.

Materials and methods
=====================

### Microarray data

Microarray data was retrieved from the GSE39058 and GSE39040 GEO (<https://www.ncbi.nlm.nih.gov/geo>). The mRNA expression of 36 OS samples from patients aged \<20 and 6 matched samples from patients aged \>20 obtained from GSE39058, based on the GPL14951 Illumina HumanHT-12 WG-DASL V4.0 R2 expression BeadChip (Illumina, Inc., San Diego, CA, USA). Similarly, a total of 58 OS samples from patients aged \<20 and 7 matched samples from patients aged \>20 were available in GSE39040, based on the GPL15762 Illumina Human v2 MicroRNA Expression BeadChip.

### Data processing

Following background correction and quartile data normalization of the original microarray data by using the robust multi-array average algorithm, probes without a corresponding gene symbol were filtered and the average value of gene symbols with multiple probes was calculated. The selected data from GSE39058 and GSE39040 were compared using R software limma package (<http://www.bioconductor.org/packages/release/bioc/html/limma.html>) to determine the differentially expressed mRNAs and miRNAs ([@b10-mmr-19-04-2729]). With a threshold of P\<0.05 and \|log~2~(fold change)\|\>1, volcano plot filtering was performed by using R software ggplot2 package v2.2 ([@b11-mmr-19-04-2729]) to identify the DEGs with statistical significance between two groups. Hierarchical clustering and combined analyses were performed for the DEGs. The differentially expressed mRNAs and miRNAs obtained were described as age-induced osteosarcoma DEMs and DEMis.

### GO and KEGG pathway enrichment analysis of DEMs

DEMs were converted to their corresponding *Homo sapiens* Entrez gene IDs using the latest database ([ncbi.nlm.nih.gov/gene](ncbi.nlm.nih.gov/gene); updated on 2018-01-01); pathway and process enrichment analysis of DEMs was performed using Metascape ([metascape.org](metascape.org)). All genes in the genome were used as the enrichment background. Terms with P\<0.05 were statistically significant. Those with a minimum count of 3 and enrichment factor \>1.5 (enrichment factor is the ratio between observed count and the count expected by chance) were collected, and grouped into clusters based on their membership similarities. More specifically, P-values were calculated based on accumulative hypergeometric distribution, q-values were calculated using the Benjamini-Hochberg procedure to account for multiple testing. κ scores were used as the similarity metric when performing hierachical clustering on the enriched terms and then sub-trees with similarity \>0.3 were considered a cluster. The most statistically significant term within a cluster was selected to represent the cluster.

### Regulatory network construction and analysis

The Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database ([string-db.org/](string-db.org/)) was used to explore the interactions among proteins encoded by the DEMs, including known proteins interactions and predicted interactions. The results were downloaded from the STRING database as a TSV file, the PPI pairs with selected larger scores were imported to the Cytoscape tool v3.4.0 ([cytoscape.org/](cytoscape.org/)) to establish PPI network. The regulatory relationship between genes were analyzed through topological property of computing network including the degree distribution of network by using the CentiScaPe2.2 app within Cytoscape ([@b12-mmr-19-04-2729]). The interaction between DEMs and DEMis was predicted using miRwalk v3.0 ([mirwalk.umm.uni-heidelberg.de/](mirwalk.umm.uni-heidelberg.de/)) with a threshold of energy \<-20, and only the interactions of miRNA and mRNA with opposite expression were included. Furthermore, the regulatory network was constructed by combining the PPI network with the predicted interactions between DEMs and DEMis. The subnetwork was extracted from the whole PPI network using the MCODE app v1.5.1 ([@b13-mmr-19-04-2729]).

### Kaplan-Meier survival analysis

In the present study, the prognostic value of the genes was confirmed by Kaplan-Meier survival analysis based on the clinical information from the GSE39040 dataset using SPSS 16.0 (SPSS, Inc., Chicago, IL, USA). For statistical analysis, the patients were divided into halves based on gene expression values. Specifically, patients with the expression values greater than the median value were classified as the high expression group and others classified as the low expression group. Log rank test (Mantel-Cox test) was used to evaluate the prognostic value of the genes.

Results
=======

### Data processing and DEG screening

DEMs of GSE39058 were obtained using R software limma package with \|log~2~(fold change)\|\>1 and P\<0.05 as the cut-off point. In OS samples from patients aged \<20, there were 1,476 up-regulated DEMs, corresponding to 1,525 probes and 637 downregulated DEMs detected by 650 probes in OS samples from patients aged \<20 compared with OS samples from patients aged \>20. The top 10 most significantly upregulated genes were SNORA17, SNORD3C, CRY1, TSEN34, NDUFA12, CNTFR, CPE, PTGS2, NKD2 and EGFL6. The top 10 most significantly downregulated genes were PPP2R2B, DSCR8, ALAS2, GPR114, NPLOC4, PDE7B, NCOA2, MRFAP1L1, LIG3 and RUNX1. Similarly, there were 15 DEMis in GSE39040, including 11 downregulated and 4 upregulated DEMis OS samples from patients aged \<20 compared with OS samples from patients aged \>20. The DEMis upregulated in OS samples from patients aged \<20 were hsa-miR-1248, hsa-miR-497, hsa-miR-1201 and hsa-miR-224. The downregulated DEMis were hsa-miR-122, hsa-miR-203, hsa-miR-205, hsa-miR-194, hsa-miR-200c, hsa-miR-183, hsa-miR-142-5p, hsa-miR-182, hsa-miR-549, hsa-miR-202\* and hsa-miR-515-5p. The volcano plot of each microarray is presented in [Fig. 1](#f1-mmr-19-04-2729){ref-type="fig"} to visualize DEGs. [Fig. 2](#f2-mmr-19-04-2729){ref-type="fig"} presented the cluster heatmaps of DEMs and DEMis.

### DEMs enrichment analysis

To determine functional enrichment, Metascape was used for GO and KEGG enrichment analysis of DEMs. GO functional enrichments and KEGG pathways of which P\<0.05 were selected as significant results ([Table I](#tI-mmr-19-04-2729){ref-type="table"}). GO analysis of DEGs includes three functional groups, namely molecular function, biological processes and cellular component. The significant GO enrichment analysis of all DEMs is presented in [Fig. 3](#f3-mmr-19-04-2729){ref-type="fig"}. GO functional enrichments and KEGG pathway analysis of up- and down-regulated DEMs were also performed using Metascape. The significant results (P\<0.05) are presented in [Figs. 4](#f4-mmr-19-04-2729){ref-type="fig"} and [5](#f5-mmr-19-04-2729){ref-type="fig"}, with details information in [Tables II](#tII-mmr-19-04-2729){ref-type="table"} and [III](#tIII-mmr-19-04-2729){ref-type="table"}. Upregulated DEMs were predominantly involved in the 'cell growth', 'response to growth factor' and 'neuron apoptotic process' and 'activation of immune response'. The downregulated DEMs were mainly involved in 'cytokine receptor activity', 'phosphoprotein phosphatase activity', 'response to decreased oxygen levels' and 'regulation of stem cell proliferation'.

### PPI network

The interactions between proteins encoded by DEMs were downloaded from the STRING database and a PPI network was created using the Cytoscape tool. Additionally, prediction of miRNA-mRNA interactions was integrated into the PPI network. After altering of the color and location of nodes, the PPI network was successfully established ([Fig. 6](#f6-mmr-19-04-2729){ref-type="fig"}). Furthermore, PPI networks of up- and down-regulated DEMs and their interacting DEMis were also constructed, and the key subnetwork was subsequently extracted using the MCODE app in Cytoscape ([Fig. 7](#f7-mmr-19-04-2729){ref-type="fig"}). The key significant genes were hsa-miR-497-5p, hsa-miR-203a-5p, hsa-miR-183-5p and hsa-miR-205-5p and the DEMs that they are known to interact with. Of note, up-regulated DEMs within the subnetwork were mainly involved in the ubiquitin-proteasome pathway (UPP), response to growth factors and the regulation of type I interferon production caused by the reduced expression levels of hsa-miR-203, hsa-miR-205 and hsa-miR-183. Furthermore, as a consequence of the overexpression of miR-497, downregulated DEMs within the hub subnetwork were closely associated with response to hypoxia, transport of potassium, activity of synapse, regulation of stem cell proliferation.

### Kaplan-Meier survival analysis

The clinical information was obtained from GSE39058 dataset. A total of 65 patients were included in the present study. The log-rank test confirmed that low expression of hsa-miR-203 (P=0.008411 and log2(fold change)=−1.247074) in aged cases was negatively associated with overall survival ([Fig. 8A](#f8-mmr-19-04-2729){ref-type="fig"}) and positively associated with recurrence rate ([Fig. 8B](#f8-mmr-19-04-2729){ref-type="fig"}) in patients with OS.

Discussion
==========

In the current study, microarray data from the GEO database was used to analyze DEGs to reveal differences in molecular mechanism introduced by age. DEMs were divided into two groups by the log~2~(fold change), then GO function enrichment and KEGG pathway analysis were performed. Furthermore, an integrated regulatory network was generated by integrating the interactions of proteins encoded by DEMs with predictions of miRNA-mRNA interactions. The potential GO functional annotations and the upstream DEMis that may induce the difference in prognosis and survival rate among ages were identified.

From analyzing the key subnetwork combined with the function enrichment analysis, it was apparent that the upregulated DEMs within the key subnetwork were mostly involved in the UPP, response to growth factors and the regulation of type I interferon production. DEMs upregulation may be caused by the reduced expression of hsa-miR-203, hsa-miR-205 and hsa-miR-183. Downregulation of DEMs is potentially caused by upregulated expression of miR-497, and this subnetwork was associated with response to hypoxia, transport of potassium, activity of synapse, regulation of stem cell proliferation.

The UPP is essential for maintaining the homeostasis, as it is responsible for intracellular protein degradation. It has a critical role in many cellular processes, including cell cycle, cell differentiation, apoptosis, anti-apoptosis and tumor development ([@b14-mmr-19-04-2729]--[@b17-mmr-19-04-2729]). The upregulated DEMs enriched in UPP were ubiquitin protein ligase E3 component n-recognin 2 (UBR2), ubiquitin conjugating enzyme E2 (UBE2) G1, UBE2D3, UBE2Z and Ran GTPase activating protein 1. Of these DEMs, UBE2G1, UBE2D3 and UBE2Z were targets of hsa-miR-203, and hsa-miR-203 was previously demonstrated to be downregulated in OS in patients \<20 years old in the current study compared with patients \>20. UBR2, the sole known E3 ubiquitin ligase of the N-end rule pathway, is reported to be upregulated in colon adenocarcinoma and Lewis lung carcinoma ([@b15-mmr-19-04-2729]). UBR2 is also demonstrated to have a pro-apoptotic function by degrading the anti-apoptotic form of tyrosine kinase Lyn, contradicting previous reports of an anti-apoptotic role, indicating that UBR2 might inhibit tumor initiation and progression ([@b14-mmr-19-04-2729]). UBE2D3, a positive prognostic factor in cancer, inhibits cell proliferation and contributes to radiosensitivity, thus improving the survival time ([@b18-mmr-19-04-2729]--[@b20-mmr-19-04-2729]). These findings suggest that UBR2, UBE2G1, UBE2D3, UBE2Z and RANGAP1, which were enriched in UPP, may serve a negative role in the development and progression of cancer; the novel association between UBE2G1 and UBE2Z and cancer requires further investigation. Liu and Feng ([@b21-mmr-19-04-2729]) reported that miR-203 was downregulated in OS tissues and cell lines, and was associated with poor survival of patients with OS. Most studies suggest that hsa-miR-203 acts as a tumor suppressor by repressing tumor growth and invasion, and downregulating hsa-miR-21; overexpression of hsa-miR-21 is described in several reported carcinogenic processes, such as invasion and metastasis and is closely associated with poor survival ([@b21-mmr-19-04-2729]--[@b23-mmr-19-04-2729]). However, Ikenaga *et al* ([@b24-mmr-19-04-2729]) reported that hsa-miR-203 was overexpressed in pancreatic adenocarcinoma and was an independent predictor of poor prognosis in patients with pancreatic adenocarcinoma. These findings indicate that hsa-miR-203 has a complex role in cancer initiation and progression as miR-203 interacts with may mRNA targets. Thus, the precise mechanism of hsa-miR-203 in tumorigenesis and progression requires further research.

Hypoxia, which is associated with tumorigenesis, tumor development, invasion and metastasis, commonly occurs in rapidly growing solid tumors, while some studies have suggested that hypoxia is a common phenomenon in OS ([@b25-mmr-19-04-2729],[@b26-mmr-19-04-2729]). Accumulating evidence suggests that hypoxia promotes tumorigenesis, tumor progression, invasion and migration ([@b26-mmr-19-04-2729]--[@b28-mmr-19-04-2729]). Heme oxygenase 2 and potassium calcium-activated channel subfamily M α 1 (KCNMA1), the downregulated DEM that was associated with response to hypoxia, may be potential target mRNAs of hsa-miR-497 and was both involved in potassium transport. It has been reported that miR-497, a hypoxia-inducible miRNA, which was suppressed in OS when compared with adjacent tissues, inhibits the expression of hypoxia-inducible factor 1-α and certain other genes ([@b29-mmr-19-04-2729],[@b30-mmr-19-04-2729]). OS samples from patients aged \<20 exhibited higher levels of miR-497 and reduced expression of downstream DEMs involved in the response to hypoxia, thus inhibiting tumor progression, which may be responsible for the improved survival of patients with OS aged \<20.

The downregulated DEMs of potentially targeted by miR-497 in OS patients aged \<20 were mainly involved in potassium transport included proteins of the potassium channel complex and transmembrane transporter complex, such as the Big Potassium (BK) ion channel, also termed KCNMA1, encoded by the DEM KCNMA1. BK channels in biological membranes facilitate the efflux of potassium from intracellular stores. Many ion channels promote cell proliferation, in including the BK channel ([@b31-mmr-19-04-2729]--[@b33-mmr-19-04-2729]). Several reports have demonstrated that BK channels have active roles in tumor growth and metastasis, and the development of drug resistance in glioma, breast cancer and prostate cancer ([@b34-mmr-19-04-2729]--[@b36-mmr-19-04-2729]); whereas Cambien *et al* ([@b37-mmr-19-04-2729]) contradicted this by reporting that the genetic knockdown of BKα promoted OS progression. Furthermore, BK channel is also reported to promote breast cancer and glioma invasion and migration ([@b38-mmr-19-04-2729],[@b39-mmr-19-04-2729]); however, there is limited evidence of the role of BK channel in OS invasion and metastasis. The findings of the current study that BK channels have a complex role in cell proliferation with numerous other factors involved. In the present study, BK channel-related genes were significantly downregulated in OS patients aged \<20, who exhibited better prognosis. Thus, we hypothesized that the active BK channel may partly contribute to poorer survival.

Age is considered to be a prognostic factor in patients with OS; however, the differences in the molecular mechanisms of OS according to age are unclear. In the current study a regulatory network for OS was created by combining PPI network and miRNA-mRNA interactions, and finally we extracted the key subnetwork by topologic analysis. The study provides some insightful information to interpret why younger patients with OS have a far more positive outcome. Furthermore, certain genes may act as potential prognostic factors and effective drug targets for treatment were identified. However, further research is required to determine the exact roles of the identified genes in OS; further investigation into the role other hub miRNAs, including hsa-miR-497, hsa-miR-183 and hsa-miR-205 in the development of OS should be conducted in the future.
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![Differentially expressed genes between two sets of samples. (A) GSE39058 data, (B) GSE39040 data. The red points represent upregulated genes screened on the basis of \|fold change\|\<2.0 and P\<0.05. The green points represent downregulated genes screened on the basis of \|fold change\|\<2.0 and P\<0.05. The blue points represent genes with no significant difference. UP, upregulated; DW, downregulated; NoDiff, no significant difference.](MMR-19-04-2729-g00){#f1-mmr-19-04-2729}

###### 

Hierarchical clustering heatmap of DEGs screened on the basis of log~2~(fold change) \<2.0 and P\<0.05. (A) GSE39058, (B) GSE39040. Orange indicates that the expression of genes is relatively upregulated; blue indicates that the expression of genes is relatively downregulated, and white indicates no significant difference.
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![GO and KEGG pathway enrichment analysis of DEMs. (A) GO and KEGG pathway enrichment analysis divided DEMs into four functional groups. (B) Statistical significance of GO and KEGG pathway enrichment of DEMs in different functional groups. DEMs, differentially-expressed mRNAs; GO, Gene Ontology; BP, biological process; CC, cellular component; KEGG, Kyoto Encyclopedia of Genes and Genomes; ECM, extracellular matrix; ERK, extracellular signal regulated-kinase.](MMR-19-04-2729-g03){#f3-mmr-19-04-2729}

![GO and KEGG pathway enrichment analysis of upregulated DEMs. (A) GO and KEGG pathway enrichment analysis divided DEMs into four functional groups. (B) Statistical significance of GO and KEGG pathway enrichment of DEMs in different functional groups. DEMs, differentially-expressed mRNAs; GO, Gene Ontology; BP, biological process; CC, cellular component; MF, molecular function; KEGG, Kyoto Encyclopedia of Genes and Genomes; cAMP, cyclic adenosine monophosphate.](MMR-19-04-2729-g04){#f4-mmr-19-04-2729}

![GO and KEGG pathway enrichment analysis of downregulated DEMs. (A) GO and KEGG pathway enrichment analysis divided DEMs into four functional groups. (B) Statistical significance of GO and KEGG pathway enrichment of DEMs in different functional groups. DEMs, differentially-expressed mRNAs; GO, Gene Ontology; BP, biological process; CC, cellular component; MF, molecular function; KEGG, Kyoto Encyclopedia of Genes and Genomes.](MMR-19-04-2729-g05){#f5-mmr-19-04-2729}

###### 

Regulatory network. (A) Regulatory network of upregulated DEGs. (B) regulatory network of downregulated DEGs. Circles represent differentially expressed mRNAs, triangles represent differentially expressed microRNAs, blue lines represent microRNA/mRNA interactions, and orange dotted lines represent protein-protein interactions. DEGs, differentially expressed genes.
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![Sub-regulatory network. (A) Sub-regulatory network of upregulated differentially expressed genes. (B) Sub-regulatory network of downregulated DEGs. Circles represent differentially expressed mRNAs, triangles represent differentially expressed microRNAs, blue lines represent microRNA/mRNA interactions, orange dotted lines represent protein-protein interactions.](MMR-19-04-2729-g08){#f7-mmr-19-04-2729}

![Survival analysis. (A) Kaplan-Meier analysis of hsa-mir-203 expression level and overall survival of patients with osteosarcoma. (B) Kaplan-Meier analysis of hsa-mir-203 expression level and recurrence rate of patients with osteosarcoma. hsa, *Homo sapiens*; miR, microRNA.](MMR-19-04-2729-g09){#f8-mmr-19-04-2729}

###### 

GO and KEGG pathway enrichment analysis for the differentially expressed mRNAs.

  Category             Term         Description                                           Count   LogP
  -------------------- ------------ ----------------------------------------------------- ------- ----------
  Canonical pathways   M3468        NABA ECM REGULATORS                                   14      −6.64807
  GO BP                GO:0002275   Myeloid cell activation involved in immune response   33      −15.539
  GO BP                GO:0006954   Inflammatory response                                 34      −12.1737
  GO BP                GO:0030316   Osteoclast differentiation                            13      −11.0649
  GO BP                GO:0007159   Leukocyte cell-cell adhesion                          21      −10.3439
  GO BP                GO:0002253   Activation of immune response                         28      −9.66921
  GO BP                GO:0050900   Leukocyte migration                                   23      −9.04039
  GO BP                GO:0019221   Cytokine-mediated signaling pathway                   28      −7.7241
  GO BP                GO:0070372   Regulation of ERK1 and ERK2 cascade                   16      −7.41007
  GO BP                GO:0006897   Endocytosis                                           26      −7.22687
  GO BP                GO:0031347   Regulation of defense response                        27      −7.11793
  GO BP                GO:0002250   Adaptive immune response                              21      −7.0625
  GO BP                GO:0051046   Regulation of secretion                               25      −6.61093
  GO CC                GO:0005773   Vacuole                                               50      −24.946
  GO CC                GO:0044440   Endosomal part                                        21      −7.19392
  KEGG pathway         hsa05323     Rheumatoid arthritis                                  19      −19.1021
  KEGG pathway         hsa04142     Lysosome                                              21      −19.026
  KEGG pathway         hsa04380     Osteoclast differentiation                            18      −14.6982
  KEGG pathway         hsa05152     Tuberculosis                                          18      −12.2416
  KEGG pathway         hsa05150     *Staphylococcus aureus* infection                       8     −6.94145

GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; ECM, extracellular matrix; ERK, extracellular signal regulated-kinase; BP, biological process; CC, cellular component.

###### 

GO and KEGG pathway enrichment analysis for the upregulated differentially expressed mRNAs.

  Category       Term         Description                                                                                Count   LogP
  -------------- ------------ ------------------------------------------------------------------------------------------ ------- ----------
  GO BP          GO:0070848   Response to growth factor                                                                  21      −5.5332
  GO BP          GO:0098909   Regulation of cardiac muscle cell action potential involved in regulation of contraction     3     −4.34678
  GO BP          GO:0051402   Neuron apoptotic process                                                                   10      −4.32756
  GO BP          GO:0016049   Cell growth                                                                                15      −4.25172
  GO BP          GO:0008380   RNA splicing                                                                               14      −4.23503
  GO BP          GO:0006986   Response to unfolded protein                                                                 8     −3.60467
  GO BP          GO:0051591   Response to cAMP                                                                             6     −3.46953
  GO BP          GO:0044770   Cell cycle phase transition                                                                15      −3.20217
  GO BP          GO:0032479   Regulation of type I interferon production                                                   6     −2.96638
  GO CC          GO:0043202   Lysosomal lumen                                                                              7     −4.47707
  GO CC          GO:0098589   Membrane region                                                                            13      −4.16789
  GO CC          GO:0005874   Microtubule                                                                                13      −3.91148
  GO CC          GO:0005793   Endoplasmic reticulum-Golgi intermediate compartment                                         6     −3.11995
  GO CC          GO:0000159   Protein phosphatase type 2A complex                                                          3     −3.01052
  GO MF          GO:0019900   Kinase binding                                                                             18      −4.1399
  GO MF          GO:0019903   Protein phosphatase binding                                                                  7     −3.87788
  GO MF          GO:0005041   Low-density lipoprotein particle receptor activity                                           3     −3.65378
  GO MF          GO:0003682   Chromatin binding                                                                          14      −3.49506
  GO MF          GO:0031625   Ubiquitin protein ligase binding                                                           10      −3.22244
  KEGG pathway   hsa04141     Protein processing in endoplasmic reticulum                                                  7     −2.98232

GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; cAMP, cyclic adenosine monophosphate; BP, biological process; CC, cellular component; MF, molecular functions.

###### 

GO and KEGG pathway enrichment analysis for the downregulated differentially expressed mRNAs.

  Category       Term         Description                               Count   LogP
  -------------- ------------ ----------------------------------------- ------- ----------
  GO BP          GO:0048489   Synaptic vesicle transport                  8     −4.97563
  GO BP          GO:0007610   Behavior                                  16      −4.08991
  GO BP          GO:0030534   Adult behavior                              7     −3.49616
  GO BP          GO:0036293   Response to decreased oxygen levels       11      −3.35132
  GO BP          GO:0018196   Peptidyl-asparagine modification            4     −3.07891
  GO BP          GO:0001843   Neural tube closure                         5     −2.90315
  GO BP          GO:0002062   Chondrocyte differentiation                 5     −2.67404
  GO BP          GO:0072091   Regulation of stem cell proliferation       4     −2.59464
  GO BP          GO:0006939   Smooth muscle contraction                   5     −2.52575
  GO CC          GO:0030424   Axon                                      18      −5.87109
  GO CC          GO:0044456   Synapse part                              21      −5.66372
  GO CC          GO:0098797   Plasma membrane protein complex           14      −3.27326
  GO CC          GO:0008076   Voltage-gated potassium channel complex     5     −2.85904
  GO CC          GO:1902911   Protein kinase complex                      5     −2.65473
  GO CC          GO:0031252   Cell leading edge                         10      −2.62652
  GO MF          GO:0004896   Cytokine receptor activity                  6     −3.68521
  GO MF          GO:0004721   Phosphoprotein phosphatase activity         8     −3.57184
  GO MF          GO:0019904   Protein domain specific binding           16      −3.127
  GO MF          GO:0008022   Protein C-terminus binding                  7     −2.72974
  KEGG pathway   hsa04950     Maturity onset diabetes of the young        4     −4.05467

GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; BP, biological process; CC, cellular component; MF, molecular functions.
